Citação norma APA

Nucera, C. (2019). A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer. Oncotarget.

Citação norma Chicago

Nucera, Carmelo. "A Novel Combined Targeted Therapy With Bromodomain Antagonist and MEK Inhibitor in Anaplastic Thyroid Cancer." Oncotarget 2019.

Citação norma MLA

Nucera, Carmelo. "A Novel Combined Targeted Therapy With Bromodomain Antagonist and MEK Inhibitor in Anaplastic Thyroid Cancer." Oncotarget 2019.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.